Monday’s HotCopper trends: DXN, Right Resources, North Stawell Minerals and other daily topics
With more than 600k average monthly users on the HotCopper forums, each and every discussion can move markets.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| PAA | PharmAust enters option to license agreement with Elanco | PRICE SENSITIVE | 18/04/18 | |
| PAA | Trading Halt | PRICE SENSITIVE | 16/04/18 | |
| PAA | Wayne Best appointed Epichem Chairman and Dr Keenan as CEO | 10/04/18 | ||
| PAA | Cleansing Notice | 20/03/18 | ||
| PAA | Change of Director's Interest Notice x 3 | 16/03/18 | ||
| PAA | Appendix 3B & s708 notice | 16/03/18 | ||
| PAA | Collaboration with Olivia Newton-John Cancer Research Inst | 14/03/18 | ||
| PAA | Appendix 4D and Half Yearly Report & Accounts | PRICE SENSITIVE | 28/02/18 | |
| PAA | PharmAust receives $354k R&D Tax Incentive Refund | PRICE SENSITIVE | 28/02/18 | |
| PAA | Results of General Meeting | 26/02/18 | ||
| PAA | Monepantel reformulation successfully improves dose & taste | PRICE SENSITIVE | 30/01/18 | |
| PAA PharmAust enters option to license agreement with Elanco | |||
| 18/04/18 | PRICE SENSITIVE | ||
| PAA Trading Halt | |||
| 16/04/18 | PRICE SENSITIVE | ||
| PAA Wayne Best appointed Epichem Chairman and Dr Keenan as CEO | |||
| 10/04/18 | |||
| PAA Cleansing Notice | |||
| 20/03/18 | |||
| PAA Change of Director's Interest Notice x 3 | |||
| 16/03/18 | |||
| PAA Appendix 3B & s708 notice | |||
| 16/03/18 | |||
| PAA Collaboration with Olivia Newton-John Cancer Research Inst | |||
| 14/03/18 | |||
| PAA Appendix 4D and Half Yearly Report & Accounts | |||
| 28/02/18 | PRICE SENSITIVE | ||
| PAA PharmAust receives $354k R&D Tax Incentive Refund | |||
| 28/02/18 | PRICE SENSITIVE | ||
| PAA Results of General Meeting | |||
| 26/02/18 | |||
| PAA Monepantel reformulation successfully improves dose & taste | |||
| 30/01/18 | PRICE SENSITIVE | ||
